chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right knee pain, swelling & fluid removal Rheumatoid arthritis to upper extremities  Generalized musculoskeletal pain UTI related to steroid use -prescribed for inflammation  & pain
had COVID in May; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (had COVID in May) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 vaccinations (second dose) and Pfizer COVID-19 vaccinations (first dose). Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccinations and Pfizer COVID-19 vaccinations.    In March 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced COVID-19 (had COVID in May). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (had COVID in May) outcome was unknown.            No concomitant drug was reported. Patient received first Moderna COVID-19 booster dose. Company comment: This spontaneous case concerns a male patient of unknown age with no reported medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred approximately 2 months after administration of third dose of mRNA-1273, the specific date of administration of third dose of mRNA-1273 and onset of the event was not specified. Initial two doses of Pfizer were administered on unspecified dates. It has been reported that the patient was treated with Paxlovid at unspecified dose and frequency. Details of concomitant medications, medical history, clinical course and treatment were not provided. The outcome of the event is unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a male patient of unknown age with no reported medical history, who experienced the unexpected, non-serious AESI of COVID-19. The event occurred approximately 2 months after administration of third dose of mRNA-1273, the specific date of administration of third dose of mRNA-1273 and onset of the event was not specified. Initial two doses of Pfizer were administered on unspecified dates. It has been reported that the patient was treated with Paxlovid at unspecified dose and frequency. Details of concomitant medications, medical history, clinical course and treatment were not provided. The outcome of the event is unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Shoulder and shoulder joint was sore and still is almost one month later. It seems to be getting worse.  It hurts to raise my arm. I am on anti-inflammatories for my hip and when I forget to take that pill, my shoulder really hurts worse. I am going to start doing rehab exercises for shoulder to see if that will help and using ice packs and heat packs.
Everything around him is moving very fast and really loud and scary, happened once yesterday for 30 sec and this one lasted for 3-5 minutes. 2nd MMR yesterday. No vomiting. No numbness and tingling. No vision changes, everything just seems to moving fast.  No dizziness, no sense of falling over. Woke up with last night with headache that improved with Motrin. Normal this morning. Mom notices that he starts breathing erratically and shuts eyes tightly. Seems a little panicked. After shot last night, more tired and cold and fell asleep at 5pm. Sneezing but no overt URI symptoms. Has felt a little warmer than normal.
Patient called on 1/29/20 and reported that she developed red, itchy bumps all over arm and shoulder at site of injection. She has been using a cold compress and stated that it had help relieve the redness, but has occurred over the course of 5 days and did not go away.
8cm erythema, induration, warmth, itching, pain + lymphadenopathy-axillary. Given Benadryl PO.
Stiff neck, throat tightened, numbness of feet p/4 doses; also in 1974-1975 had recvd some treatment probably DEV p/an exposure; no further doses will be given will do titer check;
Body aches, chills, swelling at injection site with redness, fever and complaints of some disorientation (swelling area is about halfway of right upper extremity).  Physician gave Bextra 10 mg 1 tab per mouth 3 times a day #15 tabs given.
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI
Dizziness, fell from feeling faint; h/o vasovagal episodes after shots. BPs 79/31 (pulse 50), 103/52 (pulse 46). O2 sat 100%.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-MAR-2014 the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/ 1 ml (also reported as 10 mg/1 ml) (lot # J001389, expiration date 07-NOV-2014, dose and route were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for each time were 248, 34 and R; 336, 33 and R. The storage criteria was refrigerator (R). This is one of two reports received from the same reporter. Additional information has been requested.
Approx. 15 minutes after vaccination to rt deltoid muscle, pt began breaking out on both arms with small, raised bumps.  Gave 10ml Benadryl 12,5/5 solution. Approx. 10 minutes later pt indicated he was having "a little" difficulty breathing. Dad said he has Ehlers Danlos Syndrome and that his breathing was likely due to stress reaction.  pt was ok a short time later and dad said if reaction continued, or his breathing worsened that he would take him to the ER.  I followed up with dad an hour later and dad said the bumps were still there, but son's breathing was fine.
Mother states that rash started at injection site on right thigh which varicella was administered. Mother also said that child had a temperature of 102.00.
Red, raised, red bumpy rash covering torso & back, up the back of the neck & face. Onset of rash was 10 days after vaccine administration.
Patient states she received the vaccine on the eve of 10-13-14. That night she had to be taken to the ER. Her blood pressure was 220/180, she vomited bile, and could not breathe.
05/20/2021 pt. presents to EC with cough & SOB; Hx MI at 40yo, L atrial myxoma resection, HTN, prior h/o BLE DVTs"
Sedation, Fever, NauseaVomiting, sore throat, painful swallowing Narrative:
Neck pain; Slight tingling in fingers; A spontaneous report was received from a consumer concerning a 77-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events neck pain, slight tingling in fingers.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 02ZM2014) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the patient experienced the event(s) neck pain, slight tingling in fingers.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), neck pain, slight tingling in fingers was unknown.
Patient should have received Tdap due to age 12 but received Dtap. Called and updated father of the lower dose having been given.
Information has been received from a physician concerning a 22 day old female with no medical history or allergies who on 05-SEP-2006 was vaccinated with a first "standard" dose via the "standard" route of Recombivax HB. There was no illness at the time of vaccination. There was no concomitant medication. On 6-SEP-2006 (previously reported as 25-SEP-2006) the patient developed a urticarial rash. The patient was treated with BENADRYL. No laboratory tests were performed. Subsequently on 28-SEP-2006 (previously reported as 30-SEP-2006), the patient recovered from urticaria and rash. There was no product quality complaint involved. No laboratory diagnostic tests were performed. The reporter stated that it was suggested Recombivax HB as possible etiology. Additional information is not expected.
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (experienced side effects) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Aug 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. August 2021, patient experienced vaccination complication (experienced side effects). At the time of the report, vaccination complication (experienced side effects) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
felt very tired/became tired then more tired; was very cold/very cold for 6-7 hours; Chills; Lethargic; her temperature and it was 100.8; slept most of day; no appetite; pain where the shot was given; arm hurt more, it had hurt through the night; This is a spontaneous report from a contactable consumer. This 71-year-old female consumer reported that she received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an intramuscular route of administration, administered in Arm Left on 06Feb2021 10:15 (Batch/Lot Number: EM9810) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications was not reported. The patient experienced pain where the inoculation was given in the left upper arm started on that day but got worse the next day. She explains that the next day when she woke up at 7:30 am she felt ok but then at 10 am she felt very tired and noticed her arm hurt more, it had hurt through the night. She was very, very tired and then about 10:30 am she was very cold. She had fireplace and electric heater on plus had 2 blankets on her. She asked her husband to go to the car to get her winter gloves and she was wearing scarf. This lasted 6 hours before it resolved. Her husband took her temperature, and it was 100.8. It was reported that she had no appetite during the day. Upon follow-up (16Mar2021), was reported that, 24 hours after first dose of Pfizer chills started, become tired then more tired; then slept most of day. Fever occurred throughout the day topping at 100.3 and was very cold for 6-7 hours, with 2 blankets, scarf, winter gloves while lounging in front of fireplace, plus small electric heater. The patient underwent lab tests and procedures on unspecified date which included body temperature:100.8. The action taken in response to the events for bnt162b2 was not applicable. The outcome of the events injection site pain, nasopharyngitis, decreased appetite and upon follow-up the events chills, slept most of the day, lethargic, fever was recovered and outcome for fatigue was recovering and unknown for Pain in extremity.  Follow-up (16Mar2021): this follow-up information was received from a contactable consumer and the new information reported includes, additional events was provided along with the onset date and time.   No follow-up attempts are possible. No further information is expected.
Pt received first dose of Moderna vaccine on 12/29/2020. Initial question of whether vaccine was administered correctly - administering nurse never felt arm before administering and did say she thought she gave the injection "too low" and not on deltoid. The nurse mentioned that someone else had gotten a reaction from receiving the dose "too low." Pt developed a red lump the next day at site of injection.  For first week or so, patient's symptoms decreased although she still experienced swollen lymph nodes and breast tenderness. Day 8 or 9 (1/6 or 1/7), pt woke up to arm being red, swolen, and sore again. Pt talked to infection control nurse at hospital, who advised her to go to clinic to get it seen by a provider because it looked like it might be cellulitis.  Pt presented 1/7/2021 with complaint of possible infection in right arm where she received the vaccine. Area was red, swollen, warm to the touch. Pt also had some breast tenderness. Pt was given ceftriaxone 1 gm IM x 1 in clnic and discharged.  Pt followed up the next day, 1/8/2021. At that appointment, symptoms had decreased. Redness and firmness of area had decreased and range of motion had increased. Pt continued to endorse soreness that traveled from right side of neck all the way down right elbow, but states it had decreased since 1/7.  1/12/21 pt followed up in clinic and stated arm was much better. Swelling almost gone and erythema much improved. Pt was able to use arm normally. Axilla still a little swollen, but no fever/nausea/vomiting/rash. Pt thinks she had ANA positive in past and c/f collagen vascular disease, in part because she has muscle ache flares for days to weeks. Reviewed Autoimmune panel (ANA, ESR, RA), plan to f/u with rheumatology
Fever up to 103.2 for about 34 hours; itchy macular/papular rash over torso, neck, arms and upper legs; itchy macular/papular rash over torso, neck, arms and upper legs; itchy macular/papular rash over torso, neck, arms and upper legs; myalgias; fatigue; headache; nausea; This is a spontaneous report from a contactable other hcp.   A 48-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Right on 18Feb2021 08:15 (Batch/Lot Number: EN6200), age at vaccination of 48-years-old, as single dose, for covid-19 immunisation.  Medical history included contrast media allergy from an unknown date and unknown if ongoing (IV Cat-Scan dye); patient previously took cipro [ciprofloxacin] and experienced drug hypersensitivity. The patient was not pregnant and was not pregnant at the time of vaccination. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, administered in Arm Right on 28Jan2021 for covid-19 immunisation. Concomitant medication included lansoprazole (PREVACID) taken for an unspecified indication, start and stop date were not reported.  On 18Feb2021 at 19:00, the patient experienced fever up to 103.2 F for about 34 hours, itchy macular/papular rash over torso, neck, arms and upper legs and also had expected myalgias, fatigue, headache and nausea. No treatments were given for the events. The patient underwent lab tests and procedures which included pyrexia:103.2 fahrenheit on 18Feb2021, sars-cov-2 antibody test negative in 2020.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome for the events was recovering.  Follow-up attempts completed. No further information expected.
For the date Feb, 04,2021 in a test (PCR) that are done weekly in my work, I came out positive for SARS-CoV-2 which I was in quarantine but without any type of treatment since I did not have acute symptoms. It was that my smell went away without any more symptoms.
My mother and I received the vaccines at the same time. When I received the vaccine I had excessive sweat and nausea. She did not. The day after vaccines, both my mothers and I had symptoms of a UTI. We have confirmed UTI infections.
This case was reported by a consumer and described the occurrence of seizures in a male infant a few months of age who received diphtheria and tetanus toxoids and pertussis vaccine. A physician or other health care professional has not verified this report. On an unspecified date, the patient received a dose of diphtheria and tetanus toxoids and pertussis vaccine. The reporter stated that the patient experienced a seizure, right after the DTP part. The patient was seen in a neurology department and experienced over 20 more seizures. The outcome of the event is unknown. Comment: Seizure was assessed as medically serious by the manufacturer (OMIC).
felt ill; a baseball sized lymph node swell under his arm/ She got it too; booster shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 16Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, unknown manufacturer), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 16Dec2021, outcome "unknown", described as "booster shot"; MALAISE (non-serious), outcome "unknown", described as "felt ill"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "a baseball sized lymph node swell under his arm/ She got it too".  Additional information: The patient had experienced a close to a baseball sized lymph node swell under her arm at the side of the injection in left arm. swelling had gone down to about the size of a golf ball and also felt ill.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Initial physician report received on 03 Dec 2010: This patient with an unknown medical history was vaccinated with MENVEO (batch number: unknown) on 02 Sep 2010 which was stored for around 2 months at 30 F. No adverse event was reported following this incorrect storage.
Developed hives on R upper thigh and behind R knee and both ankles.  Red, raised and itchy
Thirteen days after booster, I experienced right leg pain which progressed over the next two days to the point of excruciating pain.  I noticed both legs were swollen ,although only the right was painful.  I took Alleve and the pain and swelling started to subside over the next two days.
no adverse event; pt was inadvertently administered a dose of Recombivax that had been improperly stored; Information has been received from the licensed practical nurse (also reported as medical assistant), concerning a 4 weeks old male patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies, and concomitant medications were not provided.  On 10-JUL-2020, the patient received a dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), Lot # R034547, expiration date on 09-JUN-2021, (route and frequency were not provided) for prophylaxis.  The reporter stated that this dose was improperly stored (product storage error) for 1 hour and 49 minutes, under 0.5 grades centigrade. No previous temperature excursion was reported, and this report was obtained because of data logger. No additional adverse event was reported.
Employee states several hours p vaccine-developed chills, bodyaches and fever of 103 C 8:30 AM Approx-12 hrs p vaccine-fever lasted 9/23/09 Started returning to normal-late that evening.
Pt received vaccines and reported feeling light headed.  He was placed in a reclining position. BP was taken; 156/98. Pt was left with family to rest. Family agreed to watch him to prevent any falls from table.  His blood pressure was again checked in 5 minutes and found to have gone down to 140/86.  He was given a cool drink of water and rested approximately 10 more minutes.  At that time, pt reported he was feeling better. He was assisted to a standing position and again reported feeling better.  He left the office in the company of his mother and sister.  A call was made to him this morning and aside from soreness in his arms, he reports feeling fine.
Didn't respond to name, no eye contact, laugh when it hurt, quit crawling and trying to walk, quit talking, babbling, totally regressed. The 60 day follow-up states: My child never recovered from the "crash" that he had shortly after his one year immunizations. My child has subsequently been diagnosed as having autistic spectrum disorder. More recently one of his doctors has added the label of mild mental retardation. My child was developing normally, was meeting expected developmental milestones, beginning to talk, walk, etc. until the time of his shots. After the shots, he regressed, and developed his current symptoms.
(R) (L) Deltoid 2 inch round, red, tender. Treat with BENADRYL/hydrocortisone.
allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 20-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.   This case was linked to MOD-2021-364227 (Patient Link).
Pain in upper left arm; relieved by cortisone shot decreased range of motion; pain radiated to fingers at times. Injection given near top of left shoulder. Pain x 4 months.
Patient's Mother reported a large red area that was swollen, and hot.  Mother did not report how large, but that the area did go away after a few days.  The patient was here for follow up on 4-17-08 and mother reported incident at that time. Patient was not seen during the period of reaction.
Hands fell asleep; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient of unknown age who received BNT162B2 (COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date as unknown, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date her hands fell asleep. The outcome of event was unknown. Information on Lot/Batch number has been requested.
A week after the injection I had itchiness, swelling, redness and a firmness in the injection area. As of today I have not sought any treatment after reading about this side effect.